Skip to main content
SpringerLink
Log in
Book cover

The Handbook of Neuroprotection pp 141–216Cite as

Neuroprotection in Cerebrovascular Disease

  • Chapter
  • First Online:

  • 1236 Accesses

Abstract

Cerebrovascular disease is the term applied to a large number of diseases with pathology in the blood vessels of the brain or the vessels supplying blood to the brain. A simplified classification of cerebrovascular diseases where neuroprotection is required is shown in Table 3.1

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abe K. Gene therapy and neuroprotection for cerebral infarction. Rinsho Shinkeigaku 2003;43:894–6.

    PubMed  Google Scholar 

  • Amarenco P. Atorvastatin in prevention of stroke and transient ischaemic attack. Expert Opin Pharmacother 2007;8:2789–97.

    PubMed  CAS  Google Scholar 

  • Amaro S, Cánovas D, Castellanos M, et al. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4·5 h of onset of symptoms. Int J Stroke 2010;5:325–32.

    PubMed  Google Scholar 

  • Amemiya S, Kamiya T, Nito C, et al. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J Pharmacol 2005;516:125–30.

    PubMed  CAS  Google Scholar 

  • Arboix A, Garcia-Eroles L, Oliveres M, et al. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol 2010;10:47.

    PubMed  Google Scholar 

  • Arumugam TV, Tang SC, Lathia JD, et al. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci U S A 2007;104:14104–9.

    PubMed  CAS  Google Scholar 

  • Aslami H, Schultz MJ, Juffermans NP. Potential applications of hydrogen sulfide-induced suspended animation. Curr Med Chem 2009;16:1295–1303.

    PubMed  CAS  Google Scholar 

  • Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia; the ischemic penumbra. Stroke 1981;12:723–5.

    PubMed  CAS  Google Scholar 

  • Badin RA, Modo M, Cheetham M, et al. Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo. J Cereb Blood Flow Metab 2009;29:254–63.

    PubMed  CAS  Google Scholar 

  • Belayev L, Marcheselli VL, Khoutorova L, et al. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke 2005;36:118–23.

    PubMed  CAS  Google Scholar 

  • Benveniste M, Dingledine R. Limiting stroke-induced damage by targeting an acid channel. N Engl J Med 2005;352:85–6.

    PubMed  CAS  Google Scholar 

  • Bian Q, Shi T, Chuang DM, Qian Y. Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils. Brain Res 2007;1184:270–6.

    PubMed  CAS  Google Scholar 

  • Bondanelli M, Ambrosio MR, Onofri A, et al. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J Clin Endocrinol Metab 2006;91:3928–34.

    PubMed  CAS  Google Scholar 

  • Candelario-Jalil E, González-Falcón A, García-Cabrera M, et al. Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. J Neurochem 2007;100:1108–20.

    PubMed  CAS  Google Scholar 

  • Carloni S, Girelli S, Buonocore G, et al. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol 2009;220:82–9.

    PubMed  CAS  Google Scholar 

  • Carpenter CR, Keim SM, Crossley J, Perry JJ. Post-transient ischemic attack early stroke stratification: the ABCD(2) prognostic aid. J Emerg Med 2009;36:194–8.

    PubMed  Google Scholar 

  • Chalmers J, Chapman N. Progress in reducing the burden of stroke. Clin Exp Pharmacol Physiol 2001;28:1091–5.

    PubMed  CAS  Google Scholar 

  • Clark WM. Efficacy of citicoline as an acute stroke treatment. Expert Opin Pharmacother 2009;10:839–46.

    PubMed  CAS  Google Scholar 

  • Costa C, Martella G, Picconi B, et al. Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke 2006;37:1319–26.

    PubMed  CAS  Google Scholar 

  • Culmsee C, Junker V, Kremers W, et al. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke 2004;35:1197–202.

    PubMed  Google Scholar 

  • Davis AS, Zhao H, Sun GH, Sapolsky RM, Steinberg GK. Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neurosci Lett 2007;411:32–6.

    PubMed  CAS  Google Scholar 

  • Diener HC, Schneider D, Lampl Y, et al. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke. Stroke 2008;39:1774–8.

    PubMed  CAS  Google Scholar 

  • Digicaylioglu M. Erythropoietin in stroke: quo vadis. Expert Opin Biol Ther 2010;10:937–49.

    PubMed  CAS  Google Scholar 

  • Dobrota D, Fedorova T, Stvolinsky S, et al. Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem Res 2005;30:1283–8.

    PubMed  CAS  Google Scholar 

  • Dohi K, Satoh K, Nakamachi T, et al. Does edaravone (MCI-186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury? Antioxid Redox Signal 2007;9:281–7.

    PubMed  CAS  Google Scholar 

  • Donnan GA. The 2007 Feinberg lecture: a new road map for neuroprotection. Stroke 2008;39:242.

    PubMed  Google Scholar 

  • Dorrance AM, Rupp NC, Nogueira EF. Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia. Hypertension 2006;47:590–5.

    PubMed  CAS  Google Scholar 

  • During MJ, Symes CW, Lawlor PA, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000;287:1453–60.

    PubMed  CAS  Google Scholar 

  • Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222–9.

    Google Scholar 

  • Elzer JG, Muhammad S, Wintermantel TM, et al. Neuronal estrogen receptor-alpha mediates neuroprotection by 17 beta-estradiol. J Cereb Blood Flow Metab 2010;30:935–42.

    PubMed  CAS  Google Scholar 

  • ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665–73.

    Google Scholar 

  • Fisher M, Albers GW, Donnan GA, et al. Stroke Therapy Academic Industry Roundtable IV. Enhancing the development and approval of acute stroke therapies: stroke therapy academic industry roundtable. Stroke 2005;36:1808–13.

    PubMed  Google Scholar 

  • Fletcher L, Kohli S, Sprague SM, et al. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation. J Neurosurg 2009;111:164–70.

    PubMed  CAS  Google Scholar 

  • Fujiwara K, Date I, Shingo T, et al. Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats. J Neurosurg 2003;99:1053–62.

    PubMed  Google Scholar 

  • Gandolfo C, Sandercock P, Conti M. Lubeluzole for acute ischaemic stroke. Cochrane Database Syst Rev 2002;(1):CD001924.

    Google Scholar 

  • Garcia-Rodriguez JC, Sosa-Teste I. The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans. ScientificWorldJournal 2009;9:970–81.

    PubMed  Google Scholar 

  • Gibson CL, Bath PM, Murphy SP. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005;25:431–9.

    PubMed  CAS  Google Scholar 

  • Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006;7:437–48.

    PubMed  CAS  Google Scholar 

  • Gleeson LC, Ryan KJ, Griffin EW, et al. The beta(2)-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain Behav Immun 2010;24(8):1354–61.

    PubMed  CAS  Google Scholar 

  • Goyagi T, Toung TJ, Kirsch JR, et al. Neuroprotective {kappa}-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats. Stroke 2003;34:1533–8.

    PubMed  CAS  Google Scholar 

  • Green AR, Ashwood T. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. Curr Drug Targets CNS Neurol Disord 2005;4:109–18.

    PubMed  CAS  Google Scholar 

  • Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73.

    PubMed  CAS  Google Scholar 

  • Hendrix S, Nitsch R. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol 2007;184:100–12.

    PubMed  CAS  Google Scholar 

  • Higashi Y. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress. Expert Opin Pharmacother 2009;10:323–31.

    PubMed  CAS  Google Scholar 

  • Hiraga N, Adachi N, Liu K, et al. Suppression of inflammatory cell recruitment by histamine receptor stimulation in ischemic rat brains. Eur J Pharmacol 2007;557:236–44.

    PubMed  CAS  Google Scholar 

  • Holzer K, Feurer R, Sadikovic S, et al. Prognostic value of the ABCD2 score beyond short-term follow-up after TIA – a cohort study. BMC Neurol 2010;10:50.

    PubMed  Google Scholar 

  • Hurtado O, Moro MA, Cardenas A, et al. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis 2005;18:336–45.

    PubMed  CAS  Google Scholar 

  • Jain KK. An evaluation of zonisamide in the management of epilepsy. Expert Opin Pharmacother 2000a;1:1245–60.

    PubMed  CAS  Google Scholar 

  • Jain KK. Neuroprotective therapy for stroke. Expert Opin Investig Drugs 2000b;9:695–711.

    PubMed  CAS  Google Scholar 

  • Jain KK. Textbook of Hyperbaric Medicine, 5th ed, Hogrefe, Göttingen, 2009.

    Google Scholar 

  • Jain KK. Topiramate. In, Gilman S (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2010d.

    Google Scholar 

  • Jain KK. Hyperbaric oxygenation for the treatment of stroke. In, Gilman S (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2010b.

    Google Scholar 

  • Jain KK. Gene Therapy: Technologies, Companies and Markets. Jain PharmaBiotech Publications, Basel, 2010a.

    Google Scholar 

  • Jain KK. Scientific and Commercial Aspects of Neuroprotection. Jain Pharma Biotech Publications, Basel, 2010c.

    Google Scholar 

  • Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in blood and brain of rats subjected to transient focal ischemia. Stroke 2008;39:959–66.

    PubMed  CAS  Google Scholar 

  • Jiang ZG, Lu XC, Nelson V, et al. A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia. Proc Natl Acad Sci U S A 2006;103:1581–6.

    PubMed  CAS  Google Scholar 

  • Jiang X, Mu D, Biran V, et al. Activated Src kinases interact with the N-methyl-d-aspartate receptor after neonatal brain ischemia. Ann Neurol 2008;63:632–41.

    PubMed  CAS  Google Scholar 

  • Jiang J, Ganesh T, Du Y, et al. Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proc Natl Acad Sci U S A 2010;107:2307–12.

    PubMed  CAS  Google Scholar 

  • Jin K, Wang X, Xie L, et al. Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A 2006;103:13198–202.

    PubMed  CAS  Google Scholar 

  • Jonsson S, Cheng YF, Edenius C, et al. Population pharmacokinetic modelling and estimation of dosing strategy for NXY-059, a nitrone being developed for stroke. Clin Pharmacokinet 2005;44:863–78.

    PubMed  Google Scholar 

  • Kagiyama T, Glushakov AV, Sumners C, et al. Neuroprotective action of halogenated derivatives of l-phenylalanine. Stroke 2004;35:1192–6.

    PubMed  CAS  Google Scholar 

  • Kamei K, Maeda N, Ogino R, et al. New 5-HT1A receptor agonists possessing 1,4-benzoxazepine scaffold exhibit highly potent anti-ischemic effects. Bioorg Med Chem Lett 2001;11:595–8.

    PubMed  CAS  Google Scholar 

  • Khanna S, Roy S, Parinandi N, et al. Characterization of the potent neuroprotective properties of the natural vitamin E α-tocotrienol. J Neurochem 2006;98:1474–86.

    PubMed  CAS  Google Scholar 

  • Khosla P, Patel V, Whinter JM, et al. Postprandial levels of the natural vitamin E tocotrienol in human circulation. Antioxid Redox Signal 2006;8:1059–68.

    PubMed  CAS  Google Scholar 

  • Kim GH, Kellner CP, Hickman ZL, et al. A phase I clinical trial of tiopronin, a putative neuroprotective agent, in aneurysmal subarachnoid hemorrhage. Neurosurgery 2010;67:182–6.

    PubMed  Google Scholar 

  • Kobayashi T, Ahlenius H, Thored P, Kobayashi R, Kokaia Z, Lindvall O. Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 2006;37:2361–7.

    PubMed  CAS  Google Scholar 

  • Korde AS, Pettigrew LC, Craddock SD, et al. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. J Neurotrauma 2007;24:895–908.

    PubMed  Google Scholar 

  • Kunz A, Park L, Abe T, et al. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J Neurosci 2007;27:7083–93.

    PubMed  CAS  Google Scholar 

  • Kurozumi K, Nakamura K, Tamiya T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005;11:96–104.

    PubMed  CAS  Google Scholar 

  • Lampl Y, Boaz M, Gilad R, et al. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007;69:1404–10.

    PubMed  CAS  Google Scholar 

  • Lapchak PA, Zivin JA. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator. Stroke 2003;34:2013–8.

    PubMed  CAS  Google Scholar 

  • Lees KR, Barer D, Ford GA, et al. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke. Stroke 2003;34:482–7.

    PubMed  CAS  Google Scholar 

  • Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic stroke. N Engl J Med 2006;354:588–600.

    PubMed  CAS  Google Scholar 

  • Lin YF, Raab-Graham K, Jan YN, Jan LY. NO stimulation of ATP-sensitive potassium channels: Involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection. Proc Natl Acad Sci U S A 2004;101:7799–804.

    PubMed  CAS  Google Scholar 

  • Liot G, Roussel BD, Lebeurrier N, et al. Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity. J Neurochem 2006;98:1458–64.

    PubMed  CAS  Google Scholar 

  • Liu D, Wu L, Breyer R, Mattson MP, Andreasson K. Neuroprotection by the PGE(2) EP2 receptor in permanent focal cerebral ischemia. Ann Neurol 2005;57:758–61.

    PubMed  CAS  Google Scholar 

  • Liu K, Mori S, Takahashi HK, Tomono Y, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 2007;21:3904–16.

    PubMed  CAS  Google Scholar 

  • Luszczki JJ, Danysz W, Czuczwar SJ. Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model. Pharmacology 2008;81:259–65.

    PubMed  CAS  Google Scholar 

  • Mack WJ, Mocco J, Ducruet AF, et al. A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke. Neurosurgery 2006;59:383–8.

    PubMed  Google Scholar 

  • Marini AM, Jiang H, Pan H, Wu X, Lipsky RH. Hormesis: a promising strategy to sustain endogenous neuronal survival pathways against neurodegenerative disorders. Ageing Res Rev 2008;7:21–33.

    PubMed  CAS  Google Scholar 

  • Matchett GA, Martin RD, Zhang JH. Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms. Neurol Res 2009;31:114–21.

    PubMed  CAS  Google Scholar 

  • Mishina M, Komaba Y, Kobayashi S, et al. Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction. Neurol Med Chir (Tokyo) 2005;45:344–8.

    Google Scholar 

  • Orellana DI, Quintanilla RA, Maccioni RB. Neuroprotective effect of TNF-α against the Aβ neurotoxicity mediated by CDK5 kinase. Biochim Biophys Acta 2007;1773:254–63.

    PubMed  CAS  Google Scholar 

  • Otani H, Togashi H, Jesmin S, et al. Temporal effects of edaravone, a free radical scavenger, on transient ischemia-induced neuronal dysfunction in the rat hippocampus. Eur J Pharmacol 2005;512:129–37.

    PubMed  CAS  Google Scholar 

  • Paciaroni M, Caso V, Agnelli G. The concept of ischemic penumbra in acute stroke and therapeutic opportunities. Eur Neurol 2009;61:321–30.

    PubMed  Google Scholar 

  • Paul R, Zhang ZG, Eliceiri BP, et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001;7:222–7.

    PubMed  CAS  Google Scholar 

  • Ploughman M, Windle V, MacLellan CL, White N, Doré JJ, Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 2009;40:1490–5.

    PubMed  CAS  Google Scholar 

  • Proctor PH, Tamborello LP. SAINT-I worked, but the neuroprotectant is not NXY-059. Stroke 2007;38:e109.

    PubMed  Google Scholar 

  • Rigsby CS, Cannady WE, Dorrance AM. Aldosterone: good guy or bad guy in cerebrovascular disease? Trends Endocrinol Metab 2005;16:401–6.

    PubMed  CAS  Google Scholar 

  • Rink C, Roy S, Khan M, et al. Oxygen-sensitive outcomes and gene expression in acute ischemic stroke. J Cereb Blood Flow Metab 2010;30:1275–87.

    PubMed  CAS  Google Scholar 

  • Rodrigues CM, Spellman SR, Sola S, et al. Neuroprotection by a bile acid in an acute stroke model in the rat. J Cereb Blood Flow Metab 2002;22:463–71.

    PubMed  CAS  Google Scholar 

  • Salussolia CL, Nalwalk JW, Hough LB. Improgan-induced hypothermia: a role for cannabinoid receptors in improgan-induced changes in nociceptive threshold and body temperature. Brain Res 2007;1152:42–8.

    PubMed  CAS  Google Scholar 

  • Schabitz WR, Berger C, Kollmar R, et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 2004;35:992–7.

    PubMed  Google Scholar 

  • Schabitz WR, Steigleder T, Cooper-Kuhn CM, et al. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 2007;38:2165–72.

    PubMed  Google Scholar 

  • Schabitz WR, Kruger C, Pitzer C, et al. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab 2008;28:29–43.

    PubMed  Google Scholar 

  • Schnaudigel S, Groschel K, Pilgram SM, Kastrup A. New brain lesions after carotid stenting versus carotid endarterectomy. A systematic review of the literature. Stroke 2008;39:1911–9.

    PubMed  Google Scholar 

  • Seitz RJ, Butefisch CM. Recovery from ischemic stroke: a translational research perspective for neurology. Future Neurol 2006;1:571–86.

    Google Scholar 

  • Serebruany VL, Malinin AI, Ziai W, et al. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke. For the plavix use for treatment of stroke (PLUTO-Stroke) trial. Stroke 2005;36:2289.

    PubMed  CAS  Google Scholar 

  • Sessler DI. Defeating normal thermoregulatory defenses: induction of therapeutic hypothermia. Stroke 2009;40:e614–21.

    PubMed  CAS  Google Scholar 

  • Shah ZA, Li RC, Ahmad AS, et al. The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J Cereb Blood Flow Metab 2010;30:1951–61.

    PubMed  CAS  Google Scholar 

  • Shen H, Chen GJ, Harvey BK, et al. Inosine reduces ischemic brain injury in rats. Stroke 2005;36:654–9.

    PubMed  CAS  Google Scholar 

  • Shih AY, Friedman B, Drew PJ, et al. Active dilation of penetrating arterioles restores red blood cell flux to penumbral neocortex after focal stroke. J Cereb Blood Flow Metab 2009;29:738–51.

    PubMed  Google Scholar 

  • Shimada Y, Tsunoda H, Zang L, et al. Synergistic induction of heme oxygenase-1 by nicaraven after subarachnoid hemorrhage to prevent delayed cerebral vasospasm. Eur J Pharmacol 2009;620:16–20.

    PubMed  CAS  Google Scholar 

  • Shimazu T, Inoue I, Araki N, et al. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 2005;36:353–9.

    PubMed  CAS  Google Scholar 

  • Shuaib A, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007;357:562–71.

    PubMed  CAS  Google Scholar 

  • Shyu WC, Lin SZ, Chiang MF, et al. Neuregulin-1 reduces ischemia-induced brain damage in rats. Neurobiol Aging 2004;25:935–44.

    PubMed  CAS  Google Scholar 

  • Sila CA, Higashida RT, Clagett CP. Management of carotid stenosis. N Engl J Med 2008;358:1617–21.

    PubMed  CAS  Google Scholar 

  • Silver B, McCarthy S, Lu M, et al. Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks. J Stroke Cerebrovasc Dis 2009;18:381–3.

    PubMed  Google Scholar 

  • Stevens SL, Stenzel-Poore MP. Toll-like receptors and tolerance to ischaemic injury in the brain. Biochem Soc Trans 2006;34(Pt 6):1352–5.

    PubMed  CAS  Google Scholar 

  • Su EJ, Fredriksson L, Geyer M, Folestad E, et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 2008;14:731–7.

    PubMed  CAS  Google Scholar 

  • Suzuki S, Brown CM, Dela Cruz CD, et al. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci U S A 2007;104:6013–8.

    PubMed  CAS  Google Scholar 

  • Thompson RJ, Zhou N, MacVicar BA. Ischemia opens neuronal gap junction hemichannels. Science 2006;312:924–7.

    PubMed  CAS  Google Scholar 

  • Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 2009;111:171–80.

    PubMed  CAS  Google Scholar 

  • Wang JK, Portbury S, Thomas MB, et al. Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform. Proc Natl Acad Sci U S A 2006a;103:10461–6.

    PubMed  CAS  Google Scholar 

  • Wang Y, Alexander OB, Woodward-Pu YM, Stahl CE, Borlongan CV. Viral vector strategy for glial cell line-derived neurotrophic factor therapy for stroke. Front Biosci 2006b;11:1101–7.

    PubMed  CAS  Google Scholar 

  • Wang J, Jiang C, Liu C, et al. Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res 2010b;209:119–22.

    PubMed  CAS  Google Scholar 

  • Wang YC, Zhang S, Du TY, et al. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by stimulating autophagy in neurocyte. Brain Res 2010a;1323:149–51.

    PubMed  CAS  Google Scholar 

  • Wei X, Zhao L, Zhong J, et al. Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett 2009;462:76–9.

    PubMed  CAS  Google Scholar 

  • Won SJ, Xie L, Kim SH, et al. Influence of age on the response to fibroblast growth factor-2 treatment in a rat model of stroke. Brain Res 2006;1123:237–44.

    PubMed  CAS  Google Scholar 

  • Xu Z, Croslan DR, Harris AE, Ford GD, Ford BD. Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke. J Cereb Blood Flow Metab 2006;26:527–35.

    PubMed  CAS  Google Scholar 

  • Yepes M, Lawrence DA. Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Thromb Haemost 2004;91:457–64.

    PubMed  CAS  Google Scholar 

  • Zeynalov E, Nemoto M, Hurn PD, et al. Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide. J Cereb Blood Flow Metab 2006;26:414–20.

    PubMed  CAS  Google Scholar 

  • Zhang Y, Pardridge WM. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res 2006;1111:227–9.

    PubMed  CAS  Google Scholar 

  • Zhang R, Wang Y, Zhang L, et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 2002;33:2675–80.

    PubMed  CAS  Google Scholar 

  • Zhu S, Li M, Figueroa BE, et al. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J Neurosci 2004;24:5909–12.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jain PharmaBiotech, Blaesiring 7, Basel, 4057, Switzerland

    Kewal K. Jain

Authors
  1. Kewal K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kewal K. Jain .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Jain, K.K. (2011). Neuroprotection in Cerebrovascular Disease. In: The Handbook of Neuroprotection. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-049-2_3

Download citation

Publish with us

Policies and ethics

Search

Navigation